Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
192145011000036111 | Relenza Rotadisk (zanamivir 5 mg) powder for inhalation, 5 mg unit dose (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
192146011000036116 | Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | Is a | Relenza Rotadisk | true | Inferred relationship | Some | ||
Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | Is a | zanamivir 5 mg powder for inhalation, unit dose | true | Inferred relationship | Some | ||
Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | has intended active ingredient | zanamivir | true | Inferred relationship | Some | 1136180190 | |
Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | has unit of use | unit dose | true | Inferred relationship | Some | 1136180191 | |
Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | has Australian BoSS | zanamivir | true | Inferred relationship | Some | 1136180190 | |
Relenza Rotadisk 5 mg powder for inhalation, 5 mg unit dose | has manufactured dose form | powder for inhalation | true | Inferred relationship | Some |
Reference Sets
Trade product unit of use reference set